Metanotitia Inc. is a professional metabolomics company founded in 2018, with its headquarters in China. The company's slogan, "A professional metabolomics company focusing on the research and development of precision medicine and health products," underscores its primary focus. Metanotitia Inc. aims to transform treatment decisions and outcomes through clinically actionable diagnostics by leveraging the power of metabolomics. The founding team, with over 20 years of scientific research experience in metabolomics, transferred top-tier technology from Germany to Shenzhen, China, and is dedicated to upgrading the ProfMet metabolomics R&D platform. The company's dedication lies in combining high-quality human metabolome data with AI advances to accelerate the innovation of metabolomic IVD and integrate personalized care into the standard-of-care. Despite the absence of specific information regarding recent investments or investors, Metanotitia Inc. appears poised to make meaningful advancements in the field of precision medicine and health products.
There is no investment information
No recent news or press coverage available for Metanotitia Inc..